NRG Energy (NYSE:NRG) was upgraded by Zacks from a “sell” rating to a “buy” rating in a note issued to investors on Friday, Stock Ratings Network reports. NRG Energy Inc. (NYSE:NRG) shares after opening at $32.57 moved to $32.79 on last trade day and at the end of the day closed at $32.21. Company price to sales ratio in past twelve months was calculated as 0.93 and price to cash ratio as 4.65. NRG Energy Inc. (NYSE:NRG) showed a negative weekly performance of -0.59%.
As at present, Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) said, it is undertaking safety and equipment tests at the facility. It is also training the staff to work in the plant. If all goes well, NEPT announced that production will commence once all the permit requirements are secured, however, it hopes to launch preoperation tests early next month. In order to get things right from the earliest opportunity, the company stated that it has been working and continues to work with environmental and workers health and safety organs of the government to obtain the due permits for the plant operations. Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) shares fell -0.21% in last trading session and ended the day on $2.41.
Syntel (NASDAQ:SYNT) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, StockRatingsNetwork.com reports. They currently have a $100.00 target price on the stock. Zacks‘s price objective indicates a potential upside of 19.35% from the company’s current price. Syntel, Inc. (NASDAQ:SYNT) shares moved down -1.56% in last trading session and was closed at $83.79, while trading in range of $82.50 – $85.40. Syntel, Inc. (NASDAQ:SYNT) year to date (YTD) performance is -7.87%.
Craig Lipset, head of clinical innovation at Pfizer Inc. (NYSE:PFE) will join advocates of patient data accessibility to highlight the Blue Button initiative at the DIA 2014 50th Annual Meeting in San Diego. Pfizer Inc. (NYSE:PFE) weekly performance is -1.18%. On last trading day company shares ended up $30.25. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is -4.42%. Analysts mean target price for the company is $34.27.
Leave a Reply